Updated rationale for the initial antipsychotic selection for patients with schizophrenia

被引：0
作者：
Markota, Matej [1 ]
Morgan, Robert J. [1 ]
Leung, Jonathan G. [1 ,2 ]
机构：
[1] Mayo Clin, Dept Psychiat & Psychol, 200 First St SW, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Pharm, 200 First St SW, Rochester, MN USA
来源：
SCHIZOPHRENIA | 2024年 / 10卷 / 01期
关键词：
INTERVENTION EFFECTIVENESS CATIE; 1ST EPISODE PSYCHOSIS; DOUBLE-BLIND; 2ND-GENERATION ANTIPSYCHOTICS; NETWORK METAANALYSIS; OLANZAPINE; RISK; MORTALITY; RISPERIDONE; EFFICACY;
D O I：
10.1038/s41537-024-00492-y
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
[No abstract available]
引用
收藏
页数：6
相关论文
共 72 条
  • [1] Delayed-onset hypothesis of antipsychotic action - A hypothesis tested and rejected
    Agid, O
    Kapur, S
    Arenovich, T
    Zipursky, RB
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2003, 60 (12) : 1228 - 1235
  • [2] Argo T., 2008, Texas Medication Algorithm Project Procedural Manual: Schizophrenia Algorithm
  • [3] Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology
    Barnes, Thomas R. E.
    Drake, Richard
    Paton, Carol
    Cooper, Stephen J.
    Deakin, Bill
    Ferrier, I. Nicol
    Gregory, Catherine J.
    Haddad, Peter M.
    Howes, Oliver D.
    Jones, Ian
    Joyce, Eileen M.
    Lewis, Shon
    Lingford-Hughes, Anne
    MacCabe, James H.
    Owensm, David Cunningham
    Patel, Maxine X.
    Sinclair, Julia M. A.
    Stone, James M.
    Talbot, Peter S.
    Upthegrove, Rachel
    Wieck, Angelika
    Yung, Alison R.
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2020, 34 (01) : 3 - 78
  • [4] Clozapine Treatment and Offending: A Within-Subject Study of Patients With Psychotic Disorders in Sweden
    Bhavsar, Vishal
    Kosidou, Kyriaki
    Widman, Linnea
    Orsini, Nicola
    Hodsoll, John
    Dalman, Christina
    MacCabe, James H.
    [J]. SCHIZOPHRENIA BULLETIN, 2020, 46 (02) : 303 - 310
  • [5] Metabolic side effects in persons with schizophrenia during mid- to long-term treatment with antipsychotics: a network meta-analysis of randomized controlled trials
    Burschinski, Angelika
    Schneider-Thoma, Johannes
    Chiocchia, Virginia
    Schestag, Kristina
    Wang, Dongfang
    Siafis, Spyridon
    Bighelli, Irene
    Wu, Hui
    Hansen, Wulf-Peter
    Priller, Josef
    Davis, John M. M.
    Salanti, Georgia
    Leucht, Stefan
    [J]. WORLD PSYCHIATRY, 2023, 22 (01) : 116 - 128
  • [6] Tardive dyskinesia risk with first- and second-generation antipsychotics in comparative randomized controlled trials: a meta-analysis
    Carbon, Maren
    Kane, John M.
    Leucht, Stefan
    Correll, Christoph U.
    [J]. WORLD PSYCHIATRY, 2018, 17 (03) : 330 - 340
  • [7] Effects of age and gender on the serum levels of clozapine, olanzapine, risperidone, and quetiapine
    Castberg, I.
    Westin, A. A.
    Skogvoll, E.
    Spigset, O.
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 2017, 136 (05) : 455 - 464
  • [8] Schizophrenia, Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and number needed to treat: how can CATIE inform clinicians?
    Citrome, L.
    Stroup, T. Scott
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (08) : 933 - 940
  • [9] Mortality in people with schizophrenia: a systematic review and meta-analysis of relative risk and aggravating or attenuating factors
    Correll, Christoph U.
    Solmi, Marco
    Croatto, Giovanni
    Schneider, Lynne Kolton
    Rohani-Montez, S. Christy
    Fairley, Leanne
    Smith, Nathalie
    Bitter, Istvan
    Gorwood, Philip
    Taipale, Heidi
    Tiihonen, Jari
    [J]. WORLD PSYCHIATRY, 2022, 21 (02) : 248 - 271
  • [10] Ranking Antipsychotics for Efficacy and Safety in Schizophrenia
    Correll, Christoph U.
    Kane, John M.
    [J]. JAMA PSYCHIATRY, 2020, 77 (03) : 225 - 226
12345678